Sign inJoin waitlistJoin the waitlist

DR

Dana Rathkopf

Attending Physician · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

Weill Cornell Medical College
2004–2005
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2001–2004
New York University Hospital
1998–2001
Tulane University School of Medicine
1994–1998

Research

Integrative clinical genomics of advanced prostate cancer
Cell · 2015 · 2,800 citations
Enzalutamide in metastatic prostate cancer before chemotherapy
New England Journal of Medicine · 2014 · 2,376 citations
Abiraterone in metastatic prostate cancer without previous chemotherapy
New England Journal of Medicine · 2013 · 2,325 citations

HS
Howard Scher
64 papers
MM
Michael Morris
42 papers
MS
Matthew Smith
27 papers
SS
Susan Slovin
26 papers
CR
Charles Ryan
24 papers
DD
Daniel Danila
20 papers
Eric Small
20 papers
Andrew Armstrong
19 papers
CH
Celestia Higano
19 papers
NS
Neal Shore
19 papers
KA
Karen Autio
17 papers · 2 as a fellow
Cora Sternberg
15 papers

Clinical trials

A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer
Principal investigator · Withdrawn · Phase 1, Phase 2
Memorial Sloan Kettering Cancer Center
2024–2027
Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2020–2026
Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2016–2023
ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2014–2021